Brief: Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
29/07/2024 11:02
July 29 (Reuters) - Collegium Pharmaceutical Inc
COLL.O :
* COLLEGIUM TO ACQUIRE IRONSHORE THERAPEUTICS, EXPANDING
INTO
NEUROLOGY
* COLLEGIUM PHARMACEUTICAL INC - TO ACQUIRE IRONSHORE FOR
$525
MILLION
* COLLEGIUM PHARMACEUTICAL INC - TRANSACTION EXPECTED TO BE
IMMEDIATELY ACCRETIVE TO EBITDA
* COLLEGIUM PHARMACEUTICAL INC: REAFFIRMS 2024 FINANCIAL
GUIDANCE
FOR CURRENT BUSINESS
Source text for Eikon: ID:nGNXkyjHk
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%